TAKE Solutions Limited (TAKE.BO)
INR 16.89
(-0.18%)
INR 16.89
(-0.18%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 361.37 Million INR | 1.38% |
| 2022 | 356.46 Million INR | -27.24% |
| 2021 | 489.93 Million INR | -90.53% |
| 2020 | 5.17 Billion INR | -9.87% |
| 2019 | 5.73 Billion INR | 32.94% |
| 2018 | 4.31 Billion INR | 4677.15% |
| 2017 | 90.37 Million INR | -94.47% |
| 2016 | 1.63 Billion INR | -33.02% |
| 2015 | 2.44 Billion INR | 601.5% |
| 2014 | 348.08 Million INR | -62.9% |
| 2013 | 938.12 Million INR | -21.92% |
| 2012 | 1.2 Billion INR | 16.52% |
| 2011 | 1.03 Billion INR | -18.39% |
| 2010 | 1.26 Billion INR | 1054.54% |
| 2009 | -132.36 Million INR | 55.63% |
| 2008 | -298.29 Million INR | 60.81% |
| 2007 | -761.16 Million INR | -532.76% |
| 2006 | 175.88 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 FY | 361.37 Million INR | 1.38% |
| 2023 Q3 | 11.41 Million INR | -97.29% |
| 2023 Q1 | 107.59 Million INR | -69.82% |
| 2023 Q2 | 420.93 Million INR | 291.24% |
| 2023 Q4 | 361.37 Million INR | 3067.13% |
| 2022 Q2 | 215.57 Million INR | -26.91% |
| 2022 Q4 | 356.46 Million INR | 14.98% |
| 2022 FY | 356.46 Million INR | -27.24% |
| 2022 Q1 | 294.95 Million INR | -39.8% |
| 2022 Q3 | 310 Million INR | 43.81% |
| 2021 FY | 489.93 Million INR | -90.53% |
| 2021 Q4 | 489.93 Million INR | 49.14% |
| 2021 Q2 | 4.47 Billion INR | 1045.0% |
| 2021 Q1 | 390.45 Million INR | -92.45% |
| 2021 Q3 | 328.51 Million INR | -92.65% |
| 2020 FY | 5.17 Billion INR | -9.87% |
| 2020 Q4 | 5.17 Billion INR | 221.69% |
| 2020 Q3 | 1.6 Billion INR | -66.73% |
| 2020 Q2 | 4.83 Billion INR | 152.85% |
| 2020 Q1 | 1.91 Billion INR | -66.7% |
| 2019 Q2 | 4.87 Billion INR | 94.45% |
| 2019 Q4 | 5.73 Billion INR | 121.67% |
| 2019 FY | 5.73 Billion INR | 32.94% |
| 2019 Q1 | 2.5 Billion INR | -41.98% |
| 2019 Q3 | 2.58 Billion INR | -46.84% |
| 2018 Q1 | 4.42 Billion INR | 4800.63% |
| 2018 FY | 4.31 Billion INR | 4677.15% |
| 2018 Q4 | 4.31 Billion INR | -32.24% |
| 2018 Q3 | 6.37 Billion INR | 3928.32% |
| 2018 Q2 | 158.15 Million INR | -96.43% |
| 2017 Q1 | 1.13 Billion INR | -30.3% |
| 2017 Q2 | 1.62 Billion INR | 42.52% |
| 2017 FY | 90.37 Million INR | -94.47% |
| 2017 Q4 | 90.37 Million INR | -96.88% |
| 2017 Q3 | 2.89 Billion INR | 78.05% |
| 2016 Q1 | 1.29 Billion INR | -46.76% |
| 2016 FY | 1.63 Billion INR | -33.02% |
| 2016 Q4 | 1.63 Billion INR | -7.55% |
| 2016 Q3 | 1.76 Billion INR | 237.93% |
| 2016 Q2 | 523.49 Million INR | -59.73% |
| 2015 Q4 | 2.44 Billion INR | 72.65% |
| 2015 Q1 | 1.25 Billion INR | 261.09% |
| 2015 FY | 2.44 Billion INR | 601.5% |
| 2015 Q2 | 705.93 Million INR | -43.83% |
| 2015 Q3 | 1.41 Billion INR | 100.34% |
| 2014 Q4 | 348.08 Million INR | -72.99% |
| 2014 Q1 | 1.27 Billion INR | 35.84% |
| 2014 FY | 348.08 Million INR | -62.9% |
| 2014 Q2 | 758.17 Million INR | -40.5% |
| 2014 Q3 | 1.28 Billion INR | 69.95% |
| 2013 Q3 | 1.17 Billion INR | 9.97% |
| 2013 FY | 938.12 Million INR | -21.92% |
| 2013 Q4 | 938.12 Million INR | -20.05% |
| 2013 Q1 | 1.26 Billion INR | 5.07% |
| 2013 Q2 | 1.06 Billion INR | -15.47% |
| 2012 FY | 1.2 Billion INR | 16.52% |
| 2012 Q2 | 1.2 Billion INR | 0.0% |
| 2012 Q4 | 1.2 Billion INR | 0.0% |
| 2011 Q4 | 1.03 Billion INR | 0.0% |
| 2011 FY | 1.03 Billion INR | -18.39% |
| 2010 FY | 1.26 Billion INR | 1054.54% |
| 2009 FY | -132.36 Million INR | 55.63% |
| 2008 FY | -298.29 Million INR | 60.81% |
| 2007 FY | -761.16 Million INR | -532.76% |
| 2006 FY | 175.88 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 1.35 Billion INR | 73.326% |
| Biocon Limited | 140.18 Billion INR | 99.742% |
| Blue Jet Healthcare Limited | -830.93 Million INR | 143.49% |
| Concord Biotech Limited | -372.86 Million INR | 196.916% |
| Dishman Carbogen Amcis Limited | 18.99 Billion INR | 98.097% |
| FERMENTA BIOTECH LIMITED | 1.1 Billion INR | 67.28% |
| GENOMIC VALLEY BIOTECH LIMITED | -60.73 Thousand INR | 595104.446% |
| Lyka Labs Limited | 527.01 Million INR | 31.431% |
| Panacea Biotec Limited | -1.18 Billion INR | 130.498% |
| SAMSRITA LABS LIMITED | 21.98 Million INR | -1543.392% |
| Servoteach Industries Limited | 5016.00 INR | -7204246.093% |
| SMS Lifesciences India Limited | 992.31 Million INR | 63.583% |
| Supriya Lifescience Limited | -694.68 Million INR | 152.02% |
| Syngene International Limited | -83 Million INR | 535.386% |
| Titan Biotech Limited | 54.62 Million INR | -561.511% |
| Transgene Biotek Limited | 139.93 Million INR | -158.245% |
| Vanta Bioscience Limited | 607.93 Million INR | 40.557% |